awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38728585-5A8A1222-7AEE-4D63-8686-2674F973E8F3
Q38728585-5A8A1222-7AEE-4D63-8686-2674F973E8F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38728585-5A8A1222-7AEE-4D63-8686-2674F973E8F3
Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?
P2860
Q38728585-5A8A1222-7AEE-4D63-8686-2674F973E8F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38728585-5A8A1222-7AEE-4D63-8686-2674F973E8F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a3dcce46383f40c27c08057ad3d57d115a90ec40
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.